Prostate Cancer Cases Rising 3% Annually as Experts Renew Debate Over PSA Screening
核心洞察
The American Cancer Society estimates 333,830 new prostate cancer (搜索) cases and 36,320 deaths in the United States in 2026, with cases rising roughly 3% per year between 2014 and 2022.
The steepest increase has occurred in advanced-stage diagnoses, which ACS Chief Scientific Officer William Dahut, MD, attributes to screening conversations happening too late for too many men.
PSA testing can identify prostate cancer (搜索) six to 10 years earlier in the disease's natural history, yet experts caution that three in four men with elevated PSA do not have cancer.
Prostate cancer (搜索) cases in the United States are climbing, and a growing share of diagnoses are occurring at a more advanced stage, according to the American Cancer Society (ACS). The ACS estimates there will be 333,830 new cases of prostate cancer in 2026, alongside 36,320 deaths from the disease. In its Cancer Statistics 2026 report, the ACS found that prostate cancer cases increased by approximately 3% each year between 2014 and 2022, with the steepest increase occurring in advanced-stage diagnoses.
"We're seeing two things happen at once: more men are being diagnosed with prostate cancer (搜索), and a growing share of those cases are happening at a more advanced stage," said William Dahut, MD, chief scientific officer at the ACS. "That tells us screening conversations are happening too late for too many men, particularly those at high risk for the disease."
The ACS attributes the rise in diagnoses largely to more men being screened, although many are still not being screened early enough.
The PSA Testing Debate
At the center of the discussion is the prostate-specific antigen (搜索) (PSA) blood test, which measures a protein produced by the prostate gland. While PSA testing can help detect prostate cancer (搜索), experts often disagree on who needs the test and what the results actually mean.
"Should I get a PSA test? Should I not get a PSA test? And I think that's at the heart of the confusion," said Dr. Christopher Warlick, a urologist at the University of Minnesota.
Doctors use the test to screen for prostate cancer (搜索) because the disease can cause PSA levels to rise. However, Warlick noted that other noncancerous conditions can also elevate PSA numbers, including an enlarged prostate, which occurs as men age, urinary retention, and inflammation. The Prostate Cancer Research website reports that three out of four men with an elevated PSA level will not have cancer.
"Just because your PSA is elevated doesn't necessarily mean that you have cancer. And even if you do have cancer, it doesn't mean that it's one that's necessarily life-threatening," Warlick said.
Warlick added that some prostate cancers are so slow growing that they may never cause issues or require treatment, and PSA tests sometimes produce false positives that can lead to unnecessary biopsies or treatment.
The Case for Early Detection
Despite these limitations, Warlick emphasized the value of screening for men at risk of aggressive disease. "If you are harboring a prostate cancer (搜索) that has the potential to be life-threatening, identifying it as early as possible through PSA testing is going to be your best opportunity to affect the cure," he said.
"We think the PSA testing helps us identify a disease, perhaps six to 10 years earlier in the natural history of the disease than we would have detected it otherwise," Warlick added.
S. Adam Ramin, MD, a board certified urologist, urologic oncologist, and medical director of Urology Cancer Specialists in Los Angeles, CA, told Healthline that "the benefits of detecting prostate cancer (搜索) at an earlier, localized stage are profound." He outlined several advantages of early detection, including more treatment options such as active surveillance, surgery, and various forms of radiation therapy; higher cure rates, with localized prostate cancer carrying a nearly 100% five-year survival rate; and less aggressive treatments that can preserve urinary function and sexual health.
Screening Guidelines and Risk Factors
The United States Preventive Services Task Force recommends that men ages 55 to 69 who are not at increased risk of prostate cancer (搜索) talk to their health care providers about whether to have PSA screening. The ACS recommends that screening conversations begin at age 50 for males with average risk who are expected to live at least 10 more years, at age 45 for those at high risk, and at age 40 for males at even higher risk, including those with multiple affected relatives.
Warlick said men who have a family history of prostate cancer (搜索), have had prostate cancer, or are of African American descent may be at increased risk and should have PSA tests. The ACS reports that Black men have nearly 70% higher incidence of prostate cancer than white men, and that having a father or brother with prostate cancer more than doubles a man's risk.
Key statistics from the ACS underscore the disease's burden: 1 in 8 men will be diagnosed with prostate cancer (搜索) in their lifetime, and more than 3.5 million men with prostate cancer are still alive today. The five-year relative survival rate exceeds 99% when prostate cancer is found before it has spread to distant parts of the body.
Interpreting PSA Results
Warlick explained that what constitutes a normal PSA level depends on age, because levels rise as men get older. Generally, a value above four may indicate that something is going on, and depending on a man's risk factors and general health, further testing such as an MRI or biopsy may be warranted.
Ramin described the PSA test as "a first-alert system, a signal that something might need a closer look," noting that while an elevated PSA level does not automatically mean cancer, conditions like benign prostatic hyperplasia (搜索) (BPH) or prostatitis (搜索) can also raise PSA. If PSA levels are abnormal, a healthcare professional may recommend additional testing, such as a digital rectal exam (DRE), another type of PSA test, imaging such as an MRI, or a prostate biopsy.
"I do strongly advocate that people consider getting a PSA test in the right context. And this is really important," Warlick said.